FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Emcure Pharma IPO and Stanley Lifestyles IPO.
Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Stanley Lifestyles IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited |
Axis Capital Limited ICICI Securities Limited Jm Financial Limited SBI Capital Markets Limited |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Emcure Pharma IPO is up to ₹1,952.03 Cr whereas the issue size of the Stanley Lifestyles IPO is up to ₹537.02 Cr. The final issue price of Emcure Pharma IPO is ₹1,008.00 per share and of Stanley Lifestyles IPO is ₹369.00 per share.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
Face Value | ₹10 per share | ₹2 per share |
Issue Price (Lower) | ₹960.00 per share | ₹351.00 per share |
Issue Price (Upper) | ₹1,008.00 per share | ₹369.00 per share |
Issue Price (Final) | ₹1,008.00 per share | ₹369.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹90.00 per share | |
Market Lot Size | 14 shares | 40 shares |
Fresh Issue Size | 79,36,507 shares | 54,20,054 shares |
Fresh Issue Size (Amount) | up to ₹800.00 Cr | up to ₹200.00 Cr |
OFS Issue Size | 1,14,28,839 shares | 91,33,454 shares |
OFS Issue Size (Amount) | up to ₹1,152.03 Cr | up to ₹337.02 Cr |
Issue Size Total | 1,93,65,346 shares | 1,45,53,508 shares |
Issue Size Total (Amount) | up to ₹1,952.03 Cr | up to ₹537.02 Cr |
Emcure Pharma IPO opens on Jul 03, 2024, while Stanley Lifestyles IPO opens on Jun 21, 2024. The closing date of Emcure Pharma IPO and Stanley Lifestyles IPO is Jul 05, 2024, and Jun 25, 2024, respectively.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
Anchor Bid Date | Jul 02, 2024 | Jun 20, 2024 |
Issue Open | Jul 03, 2024 | Jun 21, 2024 |
Issue Close | Jul 05, 2024 | Jun 25, 2024 |
Basis Of Allotment (Tentative) | Jul 08, 2024 | Jun 26, 2024 |
Initiation of Refunds (Tentative) | Jul 09, 2024 | Jun 27, 2024 |
Credit of Share (Tentative) | Jul 09, 2024 | Jun 27, 2024 |
Listing date (Tentative) | Jul 10, 2024 | Jun 28, 2024 |
Anchor Lockin End date 1 | Aug 07, 2024 | Jul 26, 2024 |
Anchor Lockin End date 2 | Oct 06, 2024 | Sep 24, 2024 |
Emcure Pharma IPO P/E ratio is 34.55, as compared to Stanley Lifestyles IPO P/E ratio of 54.43.
Emcure Pharma IPO | Stanley Lifestyles IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Stanley Lifestyles Limited Financial Information (Restated Consolidated)Stanley Lifestyles Limited's revenue increased by 42.94% and profit after tax (PAT) rose by 50.64% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 98.90% | 67.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 78.24% | 56.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 34.55 | 54.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹19029.89 Cr. | ₹2103.94 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 16.90%% | 7.92%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 19.37%% | 8.63%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.67 | 0.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹29.17 | ₹6.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 16.87%% | 8.34%% |
In the Emcure Pharma IPO retail investors (RII) are offered 67,43,160 shares while in Stanley Lifestyles IPO retail investors are offered 67,43,160 shares. Qualified institutional buyers (QIB) are offered 38,53,234 shares in Emcure Pharma IPO and 29,10,702 shares in Stanley Lifestyles IPO.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
Anchor Investor Reserveration | 57,79,850 shares | 43,66,051 shares |
Market Maker Reserveration | ||
QIB | 38,53,234 shares | 29,10,702 shares |
NII | 28,89,926 shares | 21,83,026 shares |
RII | 67,43,160 shares | 50,93,728 shares |
Employee | 1,08,900 shares | 0 shares |
Others | ||
Total | 1,37,03,538 shares | 1,01,87,456 shares |
Emcure Pharma IPO subscribed 67.87x in total, whereas Stanley Lifestyles IPO subscribed 97.16x.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
QIB (times) | 191.24x | 215.62x |
NII (times) | 49.32x | 121.42x |
Big NII (times) | 54.90x | 136.75x |
Small NII (times) | 38.16x | 90.76x |
RII (times) | 7.36x | 19.08x |
Employee (times) | 8.81x | |
Other (times) | ||
Total (times) | 67.87x | 97.16x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|